Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for Fulcrum Therapeutics (FULC) over the last 7 years, with Dec 2024 value amounting to $32.2 million.

  • Fulcrum Therapeutics' Cash from Investing Activities rose 327.86% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.0 million, marking a year-over-year decrease of 29.58%. This contributed to the annual value of $32.2 million for FY2024, which is 187.84% up from last year.
  • According to the latest figures from FY2024, Fulcrum Therapeutics' Cash from Investing Activities is $32.2 million, which was up 187.84% from -$36.7 million recorded in FY2023.
  • In the past 5 years, Fulcrum Therapeutics' Cash from Investing Activities registered a high of $32.2 million during FY2024, and its lowest value of -$129.7 million during FY2021.
  • For the 3-year period, Fulcrum Therapeutics' Cash from Investing Activities averaged around $2.7 million, with its median value being $12.4 million (2022).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first slumped by 5,952.75% in 2020, then surged by 187.84% in 2024.
  • Yearly analysis of 5 years shows Fulcrum Therapeutics' Cash from Investing Activities stood at -$57.1 million in 2020, then plummeted by 126.94% to -$129.7 million in 2021, then soared by 109.57% to $12.4 million in 2022, then tumbled by 395.59% to -$36.7 million in 2023, then soared by 187.84% to $32.2 million in 2024.